Table 1. Characteristics of 1,666 persons with HIV infection prescribed primary prophylaxis against Pneumocystis jirovecii pneumonia (PCP), by nonadherence to prophylaxis – Supplement to HIV/AIDS Surveillance (SHAS) project, 2000–2004.
Characteristics | Primary PCP Prophylaxis | |
Nonadherent* | Adherent* | |
N = 305 | N = 1,361 | |
n (%) | n (%) | |
Year of SHAS interview† | ||
2000 | 45 (14.7) | 111 (8.2) |
2001 | 82 (26.9) | 407 (29.9) |
2002 | 93 (30.5) | 411 (30.2) |
2003 | 60 (19.7) | 333 (24.5) |
2004 | 25 (8.2) | 99 (7.3) |
Sex | ||
Male | 240 (78.7) | 1040 (76.4) |
Female | 65 (21.3) | 321 (23.6) |
Race/Ethnicity | ||
White, non-Hispanic | 67 (22.0) | 273 (20.1) |
Black, non-Hispanic | 179 (58.7) | 762 (56.6) |
Hispanic | 46 (15.1) | 269 (19.8) |
Other | 13 (4.3) | 57 (4.7) |
Age group (years) | ||
18–29 | 38 (12.5) | 126 (9.3) |
30–39 | 112 (40.0) | 498 (36.6) |
40–49 | 113 (37.0) | 550 (40.4) |
≥50 | 32 (10.5) | 187 (13.7) |
Employed | ||
Yes | 92 (30.2) | 383 (28.1) |
No | 213 (69.8) | 978 (71.9) |
Current annual income | ||
<$10,000 | 161 (57.8) | 666 (48.9) |
$10,000–20,000 | 53 (17.4) | 265 (19.5) |
≥$20,000 | 70 (22.9) | 322 (23.7) |
Unknown or refused to answer | 21 (6.9) | 108 (7.9) |
Education | ||
<High school/General Equivalency Diploma (GED) | 94 (30.8) | 446 (32.8) |
High school/GED | 95 (31.1) | 433 (31.8) |
>High school/GED | 116 (38.0) | 482 (35.4) |
Medical insurance | ||
Yes | 240 (78.7) | 1,075 (79.0) |
No | 65 (21.3) | 286 (21.0) |
Region of residence‡ | ||
Northeast | 25 (8.2) | 73 (5.4) |
South | 155 (50.8) | 728 (53.5) |
Midwest | 48 (15.7) | 212 (15.6) |
West | 77 (25.2) | 348 (25.6) |
Current living situation | ||
Alone | 100 (32.8) | 403 (29.6) |
With partner, family, or friend | 172 (56.4) | 837 (61.5) |
In a medical facility | 10 (3.3) | 42 (3.1) |
In shelter | 15 (4.9) | 47 (3.4) |
Other± | 8 (2.6) | 32 (2.3) |
Illicit drug use in past year§ † | ||
No | 142 (46.6) | 899 (66.0) |
Marijuana only | 54 (17.7) | 179 (13.1) |
Non-injection drugs other than marijuana | 81 (26.6) | 233 (17.1) |
Injection drug use | 28 (9.2) | 50 (3.7) |
Risk for alcoholism|| † | ||
Yes | 103 (33.8) | 328 (24.1) |
No | 202 (66.2) | 1.033 (75.9) |
Mental health described as not good ≥1 day during the last month† | ||
Yes | 232 (76.1) | 821 (60.3) |
No | 73 (23.9) | 540 (39.7) |
Recent CD4 count (cells/μL)† | ||
<200 | 160 (52.5) | 536 (39.4) |
≥200 | 77 (25.2) | 393 (28.9) |
Unknown/missing | 68 (22.3) | 432 (31.7) |
Viral load (copies/mL)† | ||
≤5000 | 108 (35.4) | 525 (38.6) |
>5,000 | 74 (24.3) | 240 (17.6) |
Unknown/missing | 123 (40.3) | 596 (43.8) |
Current PCP medication prescribed | ||
Trimethoprim-sulfamethoxazole | 243 (79.7) | 1078 (79.2) |
Dapsone | 37 (12.1) | 169 (12.4) |
Other/unknown | 25 (8.2) | 114 (8.4) |
Antiretroviral therapy (ART) in the past month† | ||
On ART, always adherent | 59 (19.3) | 910 (66.9) |
On ART, usually adherent | 125 (41.0) | 194 (14.2) |
On ART, sometimes, rarely, or never adherent | 59 (19.3) | 44 (3.2) |
On ART, unknown or missing information about adherence | 20 (6.6) | 104 (7.6) |
Not on ART | 42 (13.8) | 109 (8.0) |
Total number of pills prescribed for daily use | ||
1–3 | 87 (28.5) | 371 (27.3) |
4–5 | 120 (39.3) | 515 (37.8) |
≥6 | 98 (32.1) | 475 (34.9) |
Recruitment type | ||
Facility-based | 192 (62.9) | 894 (65.7) |
Population-based | 113 (37.0) | 467 (34.3) |
Column percentages may not total 100% because of rounding.
P-value <0.05 when comparing persons nonadherent with those adherent to PCP prophylaxis.
Regions defined by U.S. Census Bureau; for SHAS sites included in this analysis, Northeast comprises NJ, CT, and PA; South comprises GA, MD, FL, SC, DE, and TX; Midwest comprises IL, KS, MI, and MN; and West comprises AZ, CA, CO, NM, and WA.
Other responses included correctional institution, refused to answer, and other responses which did not fit into the listed response categories.
Categories are mutually exclusive.
Defined as answering yes to at least 2 of the CAGE screening questions and reporting alcohol use in the past year.